These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37492582)
21. [Pathophysiology and therapy of benign prostatic hyperplasia]. Sampson N; Madersbacher S; Berger P Wien Klin Wochenschr; 2008; 120(13-14):390-401. PubMed ID: 18726663 [TBL] [Abstract][Full Text] [Related]
22. Subtypes of white blood cells in patients with prostate cancer or benign prostatic hyperplasia and healthy individuals. Cihan YB; Arslan A; Ergul MA Asian Pac J Cancer Prev; 2013; 14(8):4779-83. PubMed ID: 24083743 [TBL] [Abstract][Full Text] [Related]
23. Usefulness of the frequency-volume chart over the International Prostate Symptom Score in patients with benign prostatic hyperplasia in view of global polyuria. Yoo S; Park J; Cho SY; Cho MC; Jeong H; Son H PLoS One; 2018; 13(7):e0197818. PubMed ID: 29995878 [TBL] [Abstract][Full Text] [Related]
24. Is there any Relationship between Total Prostate Volume, Intravesical Prostatic Protrusion and Lower Urinary Tract Symptoms in Adult Nigerian Men with Benign Prostatic Enlargement? Raphael JE; Abhulimen V West Afr J Med; 2021 Jun; 38(6):578-582. PubMed ID: 34180211 [TBL] [Abstract][Full Text] [Related]
25. Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis. Davis NF; Jack GS; Witjes WP; Bjartell A; Caris C; Patel A; de la Taille A; Lawrentschuk N; Bolton DM; Tubaro A World J Urol; 2019 May; 37(5):873-878. PubMed ID: 30145778 [TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms. De Nunzio C; Cindolo L; Gacci M; Pellegrini F; Carini M; Lombardo R; Franco G; Tubaro A Urology; 2014 Nov; 84(5):1181-7. PubMed ID: 25443931 [TBL] [Abstract][Full Text] [Related]
27. Hyperlipidemia patients with long-term statin treatment are associated with a reduced risk of progression of benign prostatic enlargement. Shih HJ; Tsai PS; Wen YC; Kao MC; Fan YC; Huang CJ Aging Male; 2020 Dec; 23(5):354-361. PubMed ID: 30058422 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for benign prostatic enlargement: The role of lifestyle habits at younger age. The #Controllati2017 initiative study group. Mirone V; Carrieri G; Morgia G; Carmignani L; Vespasiani G; Parazzini F; Artibani W Arch Ital Urol Androl; 2017 Dec; 89(4):253-258. PubMed ID: 29473372 [TBL] [Abstract][Full Text] [Related]
29. [Correlation of the platelet count in the peripheral blood with the prostate volume]. Hu XC; Liu YX; Gong YM; Xu CY; Huang T; Xiao J Zhonghua Nan Ke Xue; 2021 Feb; 27(2):140-144. PubMed ID: 34914330 [TBL] [Abstract][Full Text] [Related]
30. Clinical Implications for the Early Treatment of Benign Prostatic Enlargement (BPE): a Systematic Review. Presicce F; De Nunzio C; Tubaro A Curr Urol Rep; 2018 Jul; 19(9):70. PubMed ID: 29987480 [TBL] [Abstract][Full Text] [Related]
31. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Hammarsten J; Högstedt B Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674 [TBL] [Abstract][Full Text] [Related]
32. Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels. Kim WT; Yun SJ; Choi YD; Kim GY; Moon SK; Choi YH; Kim IY; Kim WJ J Korean Med Sci; 2011 Sep; 26(9):1214-8. PubMed ID: 21949470 [TBL] [Abstract][Full Text] [Related]
33. Correlation between body mass index and prostate volume in benign prostatic hyperplasia patients undergoing holmium enucleation of the prostate surgery. Batai K; Phung M; Bell R; Lwin A; Hynes KA; Price E; Meiklejohn KM; Bracamonte ER; Funk JT BMC Urol; 2021 Jun; 21(1):88. PubMed ID: 34112139 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the clinical parameters of benign prostate hyperplasia in diabetic and non diabetic patients. Ozcan L; Besiroglu H; Dursun M; Polat EC; Otunctemur A; Ozbek E Arch Ital Urol Androl; 2017 Mar; 89(1):26-30. PubMed ID: 28403591 [TBL] [Abstract][Full Text] [Related]
35. [Correlation between prostatic parameters of transrectal ultrasonography and age in patients with benign prostatic hyperplasia]. Cao NL; Lu QJ; Wang XH; Ni JS; Gu BJ; Hu B Zhonghua Nan Ke Xue; 2017 Apr; 23(4):315-318. PubMed ID: 29714415 [TBL] [Abstract][Full Text] [Related]
36. How can we Preserve Sexual Function after Ablative Surgery for Benign Prostatic Hyperplasia? Mykoniatis I; Renterghem KV; Sokolakis I Curr Drug Targets; 2021; 22(1):4-13. PubMed ID: 32981500 [TBL] [Abstract][Full Text] [Related]
37. Is intravesical prostatic protrusion a risk factor for hydronephrosis and renal insufficiency in benign prostate hyperplasia patients? Lu CH; Wu HHH; Lin TP; Huang YH; Chung HJ; Kuo JY; Huang WJ; Lu SH; Chang YH; Lin ATL J Chin Med Assoc; 2019 May; 82(5):381-384. PubMed ID: 30893258 [TBL] [Abstract][Full Text] [Related]
38. Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio. Kaynar M; Yildirim ME; Gul M; Kilic O; Ceylan K; Goktas S Cancer Biomark; 2015; 15(3):317-23. PubMed ID: 25586096 [TBL] [Abstract][Full Text] [Related]
39. A Population-Based Study on the Association between Benign Prostatic Enlargement and Rheumatoid Arthritis. Tzeng YM; Kao LT; Lin HC; Huang CY PLoS One; 2015; 10(7):e0133013. PubMed ID: 26172054 [TBL] [Abstract][Full Text] [Related]
40. Predictive value of novel inflammatory markers platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in arterial stiffness in patients with diabetes: A propensity score-matched analysis. Ning P; Yang F; Kang J; Yang J; Zhang J; Tang Y; Ou Y; Wan H; Cao H Front Endocrinol (Lausanne); 2022; 13():1039700. PubMed ID: 36619559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]